Ixekizumab

( DrugBank: Ixekizumab / KEGG DRUG: Ixekizumab )


8 diseases

36. 表皮水疱症


臨床試験数 : 183薬物数 : 159 - (DrugBank : 51) / 標的遺伝子数 : 69 - 標的パスウェイ数 : 147 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

37. 膿疱性乾癬(汎発型)


臨床試験数 : 93薬物数 : 50 - (DrugBank : 21) / 標的遺伝子数 : 21 - 標的パスウェイ数 : 99 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

46. 悪性関節リウマチ


臨床試験数 : 4,543薬物数 : 2,251 - (DrugBank : 390) / 標的遺伝子数 : 198 - 標的パスウェイ数 : 232 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

107. 若年性特発性関節炎


臨床試験数 : 477薬物数 : 232 - (DrugBank : 53) / 標的遺伝子数 : 66 - 標的パスウェイ数 : 160 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

160. 先天性魚鱗癬


臨床試験数 : 57薬物数 : 68 - (DrugBank : 25) / 標的遺伝子数 : 21 - 標的パスウェイ数 : 141 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

162. 類天疱瘡(後天性表皮水疱症を含む。)


臨床試験数 : 128薬物数 : 108 - (DrugBank : 49) / 標的遺伝子数 : 35 - 標的パスウェイ数 : 143 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

269. 化膿性無菌性関節炎・壊疽性膿皮症・アクネ症候群


臨床試験数 : 32薬物数 : 32 - (DrugBank : 16) / 標的遺伝子数 : 17 - 標的パスウェイ数 : 106 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

271. 強直性脊椎炎


臨床試験数 : 603薬物数 : 302 - (DrugBank : 69) / 標的遺伝子数 : 40 - 標的パスウェイ数 : 146 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries